INSIGHTS ON DRUG DEVELOPMENT

• Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

  Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.

• Highly Sensitive ELISAs In 90 Minutes

  Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.

• Spray Dried Biologics For Pulmonary Dosage Forms

  View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.

• Detect Low-Abundance GLP-1 Impurities With Greater Sensitivity

  Low-level impurities can be difficult to resolve using conventional approaches. Discover how a Charged Surface 2.3 µm superficially porous Phenyl-Hexyl column enhances reversed-phase LC-MS analysis.

• Cross-Site Work Within Cambrex's Network

  7/24/2026

  Matthew Zart, Group Leader of Analytical Development, on what happens when a method arrives from another site — inheriting Phase II work from High Point and getting it commercial-ready for the QC lab.

• De-Risking Drug Development: Informatics-Supported Solid Form Selection

  5/6/2026

  Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.

• Sterilization Of APIs – The Alternative: Sterile Filtration Following Aseptic Processing

  5/21/2026

  When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.

• Approaching Process Validation During Tech Transfer To Commercial Manufacturing

  7/23/2026

  Matthew Schiesher, Head of R&D at Cambrex Charles City, on validating processes under the clock — and how running multiple sites in parallel shortens the path to launch when patients are waiting.

• How Data-Driven Development Is Transforming Phosphoramidites

  7/17/2026

  High-quality phosphoramidites are key to oligonucleotide therapies. Learn how data-driven optimization boosts purity, streamlines manufacturing, speeds scale-up, and supports commercialization.